Document is current
Any future updates will be listed below
-
Authors
Grimaldi, Gabriela
Cancian, Giuseppe
Paris, Arianna
Clerici, Michele
Volpe, Giulio
Menghini, Moreno
- License Information
-
More Information
Article History
Received: 5 August 2024
Accepted: 10 September 2024
First Online: 30 September 2024
Declarations
:
: This study protocol was reviewed and approved locally by the ethics committee of Canton Ticino (CE 4340), with approval number 2023 − 00653. Written informed consent was obtained from all patients.
: Not applicable.
: GG provided consulting and/or speaker services for Abbvie, Apellis, Bayer and Roche. MM provided consulting and/or speaker services for Abbvie, Apellis, Bayer, Endogena Inc, Novartis, Roche and holds equity of Endogena Inc.
